e-Drug3D 132 |
METHSCOPOLAMINE
|
cas 13265-10-6 |
CLASS METABOLISM |
ROUTE (list) ORAL |
PK parameters F 17 PERCENT Solubility FREELY SOLUBLE IN WATER |
Target TARGET MUSCARINIC ACETYLCHOLINE RECEPTOR PDB Ligand code = 3C0 (link to the list of PDB complexes) Download experimental 3D coordinates of 3C0 with added hydrogens |
DrugCentral Muscarinic acetylcholine receptor M1 UNIPROT P11229 CHRM1 Muscarinic acetylcholine receptor M3 UNIPROT P20309 CHRM3 |
Download SDF file | 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-,(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)- Formula: Calculated chemical properties: MW 318.38 NB_atoms 23 XLogP 1.06 PSA 48.838 NB_HD 1 NB_HA 4 fsp3 0.61 Lipinski(0=no;1=yes) 1 |
FDA NDA 008848 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) PAMINE (FOUGERA PHARMS) APPROVAL= AP YEAR= 1953 DISCONTINUED NDA 080970 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) METHSCOPOLAMINE BROMIDE (PVT FORM) APPROVAL= AP YEAR= 1976 DISCONTINUED NDA 040624 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) METHSCOPOLAMINE BROMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 040642 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) METHSCOPOLAMINE BROMIDE (BRECKENRIDGE PHARM) APPROVAL= AP YEAR= 2011 NDA 200602 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) METHSCOPOLAMINE BROMIDE (UNICHEM) APPROVAL= AP YEAR= 2012 NDA 216786 (pdf not found) INN (METHSCOPOLAMINE BROMIDE) METHSCOPOLAMINE BROMIDE (NE RX PHARMA) APPROVAL= AP YEAR= 2024 |
Other links: |